Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06662500 · ClinicalTrials.gov registry record · NA
FORWARD CAD IDE Study
A NA study of Coronary Arterial Disease (CAD), sponsored by Shockwave Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 408
- Enrollment target
- 20
- Study locations
NCT06662500 is a NA study of Coronary Arterial Disease (CAD) that is actively recruiting participants, run by Shockwave Medical. The registered enrollment target is 408 participants, below the 2,997-participant average among 5 other Coronary Arterial Disease (CAD) trials with a reported enrollment target (86% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT06662500, a NA study of Coronary Arterial Disease (CAD), is actively recruiting participants, sponsored by Shockwave Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 408 participants
- Enrollment target
- 20
- Study locations
Study Summary
The FORWARD CAD IDE Study is a Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study conducted to assess the safety and effectiveness of the Shockwave Intravascular Lithotripsy (IVL) System with the Javelin Coronary IVL Catheter for the treatment of calcified, stenotic de novo coronary artery lesions prior to stenting.
Conditions Studied
Interventions
- DEVICE Intravascular Lithotripsy
Study Locations (20)
New York
- NYU Langone Health - New York
- Columbia University Medical Center/New York Presbyterian Hospital - New York
- Lenox Hill Hospital - New York
- St. Francis Hospital & Heart Center - Roslyn
Massachusetts
- Massachusetts General Hospital - Boston
- Brigham and Women's Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
California
- Scripps Health - La Jolla
- University of California, San Francisco - San Francisco
Georgia
- Piedmont Heart Institute - Atlanta
- Emory University Hospital - Atlanta
Colorado
- South Denver Cardiology Associates, P.C - Littleton
Connecticut
- Hartford Hospital - Hartford
District of Columbia
- Medstar Washington Hospital Center - Washington D.C.
Florida
- The Cardiac and Vascular Institute - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 408 participants |
| Start Date | 2025-04-04 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06662500
The ClinicalTrials.gov registry entry for NCT06662500 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 408 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 5 other Coronary Arterial Disease (CAD) trials with a reported enrollment target (86% lower). The listed sponsor is Shockwave Medical, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Arterial Disease (CAD) appearing as the primary indexed condition, and to 1 intervention - of which Intravascular Lithotripsy is the first listed.
NCT06662500 reports 20 study locations spanning 13 distinct geographic areas - top geographies include New York, Massachusetts, California.
Frequently Asked Questions
What is clinical trial NCT06662500 about?
NCT06662500 is a clinical study titled "FORWARD CAD IDE Study". The FORWARD CAD IDE Study is a Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study conducted to assess the safety and effectiveness of the Shockwave Intravascular Lithotripsy (IVL) System with the Javelin Coronary IVL Catheter for the treatment of calcified, stenotic d...
What is the current status of trial NCT06662500?
This trial is currently recruiting. It is a NA study. The enrollment target is 408 participants. The study started on 2025-04-04. Estimated completion is 2027-12.
What conditions does trial NCT06662500 study?
This clinical trial studies the following conditions: Coronary Arterial Disease (CAD).
What interventions are being tested in trial NCT06662500?
The interventions under investigation include: Intravascular Lithotripsy (DEVICE).
Who is sponsoring clinical trial NCT06662500?
This trial is sponsored by Shockwave Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06662500 being conducted?
This trial has 20 study locations across California, Colorado, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Arterial Disease (CAD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
RECRUITING · NA
-
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
RECRUITING · Phase 2
-
Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)
RECRUITING · Phase 4
-
The Switching Antiplatelet-9 (SWAP-9) Study
RECRUITING · Phase 4
-
Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.